This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,816.71, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through December 30, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating open competition.
In addition to this delivery order, AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/28/25, 10:58 AM